Dejin Zheng

5PUBLICATIONS
19CO-AUTHORS
Molecular targetsExperimental methods in fluid flow, heat and mass transferSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 11, 2026
TP53 Loss Elevates NF-κB-IFN-β-MHC-Ia Signaling to Promote NK Cell Resistance in Osteosarcoma.

|Nov 20, 2025
SOX2 is a dispensable modulator of NUT carcinoma oncogenesis in mice.

Chenxiang Luo, Dejin Zheng, Ahmed Elnegiry

|Aug 25, 2025
Tissue-specific consequences of tag fusions on protein expression in transgenic mice.

Gillian C A Taylor, Lewis Macdonald, Natalia A Szulc

|Aug 12, 2025
SOX2 is a dispensable modulator of NUT carcinoma oncogenesis in mouse.

Chenxiang Luo, Dejin Zheng, Ahmed Elnegiry

|May 09, 2024
Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo.

Dejin Zheng, Ahmed A Elnegiry, Chenxiang Luo

Pageof 1